Hester M. Den Ruijter

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 268 publications

Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial.

Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial.

Journal: Journal of the American College of Cardiology
Published: July 21, 2026

Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention.

Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: July 20, 2026

Natriuretic peptide responses to exercise in HFpEF diagnosis: a pilot study.

Natriuretic peptide responses to exercise in HFpEF diagnosis: a pilot study.

Journal: Open heart
Published: June 14, 2026

Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes.

Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes.

Journal: European heart journal
Published: May 06, 2026

Female-Biased VSMC GRNs Predict MYH9 as Regulator of Fibrous Plaque Phenotype.

Female-Biased VSMC GRNs Predict MYH9 as Regulator of Fibrous Plaque Phenotype.

Journal: Circulation research
Published: April 15, 2026

Female-Biased VSMC GRNs Predict MYH9 as Regulator of Fibrous Plaque Phenotype.

Female-Biased VSMC GRNs Predict MYH9 as Regulator of Fibrous Plaque Phenotype.

Journal: Circulation research
Published: April 15, 2026

Diagnostic Yield and Safety of Invasive Coronary Function Testing After Radial Versus Femoral Access.

Diagnostic Yield and Safety of Invasive Coronary Function Testing After Radial Versus Femoral Access.

Journal: Circulation. Cardiovascular interventions
Published: March 29, 2026

Incorporating angina into the H2FPEF score improves diagnostic performance for HFpEF in women.

Incorporating angina into the H2FPEF score improves diagnostic performance for HFpEF in women.

Journal: Open heart
Published: February 19, 2026

Atherosclerotic Fibrous Plaques in Women Present ECM Remodeling Linked to TGF-β.

Atherosclerotic Fibrous Plaques in Women Present ECM Remodeling Linked to TGF-β.

Journal: Circulation research
Published: February 05, 2026

Voices of those recruiting: A qualitative study on barriers and enablers to women's participation in cardiovascular trials.

Voices of those recruiting: A qualitative study on barriers and enablers to women's participation in cardiovascular trials.

Journal: Atherosclerosis
Published: February 04, 2026

Rationale and design of the vericiguat in vasospastic angina (ViVA) trial: A double-blind placebo-controlled randomized cross-over study.

Rationale and design of the vericiguat in vasospastic angina (ViVA) trial: A double-blind placebo-controlled randomized cross-over study.

Journal: American heart journal
Published: December 04, 2025

Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patients.

Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patients.

Journal: International journal of cardiology
Published: December 04, 2025
Showing 1-12 of 268

Last Updated: 09/26/2026